These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 25448099

  • 1. A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.
    Hu W, Zhang H, Han Q, Li L, Chen Y, Xia N, Chen Z, Shu Y, Xu K, Sun B.
    Vaccine; 2015 Jan 03; 33(2):374-81. PubMed ID: 25448099
    [Abstract] [Full Text] [Related]

  • 2. High-yield production of a stable Vero cell-based vaccine candidate against the highly pathogenic avian influenza virus H5N1.
    Zhou F, Zhou J, Ma L, Song S, Zhang X, Li W, Jiang S, Wang Y, Liao G.
    Biochem Biophys Res Commun; 2012 May 18; 421(4):850-4. PubMed ID: 22554519
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mutation of Influenza A Virus PA-X Decreases Pathogenicity in Chicken Embryos and Can Increase the Yield of Reassortant Candidate Vaccine Viruses.
    Hussain S, Turnbull ML, Wise HM, Jagger BW, Beard PM, Kovacikova K, Taubenberger JK, Vervelde L, Engelhardt OG, Digard P.
    J Virol; 2019 Jan 15; 93(2):. PubMed ID: 30381488
    [Abstract] [Full Text] [Related]

  • 8. Generation of a High-Growth Influenza Vaccine Strain in MDCK Cells for Vaccine Preparedness.
    Kim EH, Kwon HI, Park SJ, Kim YI, Si YJ, Lee IW, Kim SM, Kim SI, Ahn DH, Choi YK.
    J Microbiol Biotechnol; 2018 Jun 28; 28(6):997-1006. PubMed ID: 29642288
    [Abstract] [Full Text] [Related]

  • 9. Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics.
    Ozaki H, Govorkova EA, Li C, Xiong X, Webster RG, Webby RJ.
    J Virol; 2004 Feb 28; 78(4):1851-7. PubMed ID: 14747549
    [Abstract] [Full Text] [Related]

  • 10. Reassortment of high-yield influenza viruses in vero cells and safety assessment as candidate vaccine strains.
    Zhou J, Yang F, Yang J, Ma L, Cun Y, Song S, Liao G.
    Hum Vaccin Immunother; 2017 Jan 02; 13(1):111-116. PubMed ID: 27648636
    [Abstract] [Full Text] [Related]

  • 11. Improvement of the H5N1 influenza virus vaccine strain to decrease the pathogenicity in chicken embryos.
    Isoda N, Sakoda Y, Okamatsu M, Tsuda Y, Kida H.
    Arch Virol; 2011 Apr 02; 156(4):557-63. PubMed ID: 21203786
    [Abstract] [Full Text] [Related]

  • 12. Increase in viral yield in eggs and MDCK cells of reassortant H5N1 vaccine candidate viruses caused by insertion of 38 amino acids into the NA stalk.
    Zhang W, Xue T, Wu X, Zhang P, Zhao G, Peng D, Hu S, Wang X, Liu X, Liu W, Liu X.
    Vaccine; 2011 Oct 19; 29(45):8032-41. PubMed ID: 21864614
    [Abstract] [Full Text] [Related]

  • 13. A single NS2 mutation of K86R promotes PR8 vaccine donor virus growth in Vero cells.
    Zhang H, Han Q, Ping X, Li L, Chang C, Chen Z, Shu Y, Xu K, Sun B.
    Virology; 2015 Aug 19; 482():32-40. PubMed ID: 25817403
    [Abstract] [Full Text] [Related]

  • 14. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H, Liu XF, Zhang X, Chen S, Sun L, Lu J.
    Vaccine; 2007 Oct 16; 25(42):7379-84. PubMed ID: 17870216
    [Abstract] [Full Text] [Related]

  • 15. Development of high-yield influenza A virus vaccine viruses.
    Ping J, Lopes TJS, Nidom CA, Ghedin E, Macken CA, Fitch A, Imai M, Maher EA, Neumann G, Kawaoka Y.
    Nat Commun; 2015 Sep 02; 6():8148. PubMed ID: 26334134
    [Abstract] [Full Text] [Related]

  • 16. Generation and evaluation of reassortant influenza vaccines made by reverse genetics for H9N2 avian influenza in Korea.
    Song JM, Lee YJ, Jeong OM, Kang HM, Kim HR, Kwon JH, Kim JH, Seong BL, Kim YJ.
    Vet Microbiol; 2008 Aug 25; 130(3-4):268-76. PubMed ID: 18374520
    [Abstract] [Full Text] [Related]

  • 17. Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content.
    Abt M, de Jonge J, Laue M, Wolff T.
    Vaccine; 2011 Jul 18; 29(32):5153-62. PubMed ID: 21624413
    [Abstract] [Full Text] [Related]

  • 18. The PB1 segment of an influenza A virus H1N1 2009pdm isolate enhances the replication efficiency of specific influenza vaccine strains in cell culture and embryonated eggs.
    Mostafa A, Kanrai P, Ziebuhr J, Pleschka S.
    J Gen Virol; 2016 Mar 18; 97(3):620-631. PubMed ID: 26743314
    [Abstract] [Full Text] [Related]

  • 19. Effect of gene constellation and postreassortment amino acid change on the phenotypic features of H5 influenza virus reassortants.
    Rudneva IA, Timofeeva TA, Shilov AA, Kochergin-Nikitsky KS, Varich NL, Ilyushina NA, Gambaryan AS, Krylov PS, Kaverin NV.
    Arch Virol; 2007 Mar 18; 152(6):1139-45. PubMed ID: 17294090
    [Abstract] [Full Text] [Related]

  • 20. Improvement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34.
    Pan W, Dong Z, Meng W, Zhang W, Li T, Li C, Zhang B, Chen L.
    Hum Vaccin Immunother; 2012 Feb 18; 8(2):252-9. PubMed ID: 22426370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.